Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Table 2 Characteristics of the groups
| Total (n = 9) | Angiosarcoma (n = 5) | Undifferentiated sarcoma (n = 4) | P value | |
| Age (range)1 | 57 (2-62) | 57 (2-62) | 56 (48-60) | 0.999 |
| Sex, male (%) | 5 (55.6) | 4 (80) | 1 (25) | 0.120 |
| Largest tumor size (cm)1 | 13.0 | 7.3 | 18.5 | 0.142 |
| Tumor number1 | 1.0 | 2 | 1 | 0.371 |
| AFP1 | 2.8 | 2.6 | 2.8 | 0.999 |
| CA19-91 | 13.2 | 3.2 | 1970 | 0.180 |
| Recurrence (%) | 9 (100) | 5 (100) | 4 (100) | 0.999 |
| Disease-free survival days1 | 52 (0-1798) | 53 (36-1798) | 35 (0-439) | 0.221 |
| Death (%) | 7 (77.8) | 4 (80) | 3 (75) | 0.866 |
| Survival days1 | 402 | 402 | 596 | 0.806 |
- Citation: Kim SJ, Rhu J, Kim JM, Choi GS, Joh JW. Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience. World J Hepatol 2021; 13(5): 584-594
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.584